MEDIA RELEASE: ASIAN FUND FOR CANCER RESEARCH
HONG KONG, 24 January 2022: The Asian Fund for Cancer Research (AFCR) has announced that internationally recognised leader, Lance Kawaguchi, has been appointed as the newest member of the Board of Directors.
The AFCR is committed to funding cancer research and promoting high-impact global collaborations to improve outcomes for cancer patients. The organisation is focused on funding and supporting innovative discovery and translational projects that unlock new information about how cancer forms and spreads, and how to treat it.
Founder and CEO of AFCR, Dr. Sujuan Ba says, “Lance’s strong experience globally across finance, banking, and not-for-profit (NFP) will bring a unique perspective to the Board. As a globally recognised leader in digital transformation, operational efficiencies, and diversity & inclusion, Lance’s passion for supporting early-stage oncology startups aligns with the vision of AFCR. Lance is a visionary leader and we look forward to his contribution as we expand AFCR’s reach across the Asia Pacific region.”
Lance Kawaguchi is an internationally recognised executive leader and board member, with over 25 years of global finance and banking experience, including living and working throughout North America, Europe, Asia Pacific, and the Middle East. His current appointment as CEO of Cure Brain Cancer Foundation is a testament to his strong, advocating vision for supporting people and families living with cancer, by supporting innovative research to drive outcomes for those affected by the disease.
Led by Chairman Gary Gee Nung Wong, the Board is comprised of internationally recognised experts in the Asia-Pacific region across private equity, biotechnology, healthcare, legal, and the medical sector. Their combined knowledge and expertise strengthen the governance and global reputation of AFCR. The appointment of Mr Kawaguchi will be the first appointment of an Australian based executive to this group of industry leaders, lending new insight and creating synergies in the Region.
"I believe that cancer is a global problem and therefore requires a global effort to find a cure. Sharing expertise in the Asia-Pacific region will greatly benefit the cancer community," said Lance Kawaguchi, CEO of Cure Brain Cancer Foundation. “I am honoured to be the first Australian representative to join the Asian Fund for Cancer Research Board and look forward to building these important, international relationships to benefit cancer patients.”
This appointment is aligned with the mission of AFCR, to promote global collaborations to create impact and make a difference to the lives of those diagnosed with cancer.
About Asian Fund for Cancer Research
The Asian Fund for Cancer Research Limited (AFCR) is committed to funding cancer research, especially those cancers prevalent in Asian populations, and promote global collaborations for high impact to save the lives of cancer patients.
AFCR provides the public with a wide variety of in-depth, user-friendly cancer prevention information and healthy lifestyle suggestions. We help the community understand the latest scientific achievements and their potential significance to improve the prevention, diagnosis and treatment of cancer. Armed with this knowledge, people can better protect themselves against cancer.
About Cure Brain Cancer Foundation
Cure Brain Cancer Foundation is an Australian-based organisation, which is working globally to rapidly improve brain cancer survival. The Foundation’s mission is to unite the community and rapidly increase brain cancer survival, improving quality of life for people impacted by the disease, with a vision to ultimately find a cure for brain cancer. We’ll achieve this by empowering people living with brain cancer to have a strong influential voice, while raising awareness and funding for innovative research to accelerate quality treatments to patients.
For Media Enquiries:
Patrice Pandeleos, Seven Communications
+61 405 995 050
Varsha Kumar, Seven Communications